| Snapshot Aspect | Data and Details |
| Base Year for Estimate | 2023 |
| Forecast Period | 2023 - 2028 |
| Market Size in 2023 | $1.45 billion |
| CAGR | 11.2% |
| Projected Market Size in 2028 | $2.46 billion |
| Company | Date | Type | Event |
|
Biosense Webster
|
7/2023 | Commercial Milestone | Biosense Webster announced the company began commercialization of its OPTRELL Mapping Catheter. |
|
Boston Scientific
|
4/2024 | Clinical Milestone | Boston Scientific began its NAVIGATE-PF study, which combines its FARAWAVE Nav PFA catheter with its FARAVIEW Software Module, enabling PFA therapy and mapping in the same device. |
Trusted By The Companies Pioneering What’s Next
17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2025 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy